Sunday, December 14, 2025

LATEST ARTICLES

Medtech

Happify Health to Distribute its Clinical-Grade, Intelligent Healing Platform Through Microsoft Azure

Life Sciences Times - 0
Public Health

Soleo Health Selected by Houston Methodist as Exclusive In-Home Provider of Infused Monoclonal Antibodies for Treatment of COVID-19

Life Sciences Times - 0
People on the Move

NextGen Healthcare Appoints David Sides President and Chief Executive Officer

Life Sciences Times - 0
Venture Capital

3D BioFibR Inc. Raises New Capital to Scale Up Manufacturing in an Oversubscribed Round

Life Sciences Times - 0
Venture Capital

Thomas H. Lee Partners to Acquire Automation Business from Brooks Automation for $3 Billion in Cash

Life Sciences Times - 0
Venture Capital

Illumina Ventures Closes $325 Million Fund

Life Sciences Times - 0
Pharma

Invetx Announces Initiation of First Clinical Study in Dogs with IVX-01, its Novel Monoclonal Antibody Featuring Half-Life Extension

Life Sciences Times - 0
Pharma

Exelixis Announces Detailed Phase 1b Results from Cohort 6 of COSMIC-021 Trial

Life Sciences Times - 0
Pharma

SpectrumX’s SPC-069 Respiratory Treatment Shows Unprecedented Efficacy against Multiple Coronavirus Variants

Life Sciences Times - 0
Pharma

Pfizer and BioNTech Announce Positive Topline Results From Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years

Life Sciences Times - 0
1...670671672...770Page 671 of 770

Most Popular

Load more

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv